跳至主要内容
临床试验/NCT07560644
NCT07560644尚未招募2 期

Restoring Sinus Rhythm Using DUAL-electrical SHOCK Technique: the DUAL-SHOCK Trial

Martín Negreira Caamaño, MD, PhD0 个研究点目标入组 177 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
177
主要终点
Primary Efficacy Outcome - Patients achieving sinus rhythm with the first shock

研究概览

简要总结

The goal of this clinical trial is to assess the efficacy and acute safety of the dual electrical cardioversion (ECV) technique compared with the conventional ECV in patients with persistent atrial fibrillation. The main question it aims to answer are:

  • Is dual ECV more effective than conventional ECV to achieve sinus rhythm restoration?
  • Is dual ECV safe compared with conventional ECV?
  • Which are the main factors associated with cardioversion success?

Researchers will compare a dual ECV technique with 400J with dual ECV with 200J and conventional ECV.

Participants will be randomized to one ECV configuration. The primary efficacy endpoint will be considered the percentage of patients with successful cardioversion with the first shock. The coprimary safety endpoint will be the occurrence of adverse events during ECV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

The outcome of the randomization will be concealed from the patient (single-blind study). All patients will be provided with two sets of defibrillation pads to conceal the intervention they ultimately receive. The analysis of the results will be conducted with the statistical team blinded to the assigned intervention group.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of persistent AF.
  • Effective anticoagulation for at least 3 weeks prior to the procedure or exclusion of intra-atrial thrombus by transesophageal echocardiography within the last 24 hours.
  • Informed consent obtained.

排除标准

  • Long-standing persistent atrial fibrillation (more than 1 year of uninterrupted AF rhythm).
  • Emergency indication (hemodynamic instability).
  • Cardiac defibrillation following catheter ablation procedures. Cardiac defibrillation performed during the same procedure will be permitted if it is carried out prior to ablation.
  • Pregnancy.
  • Age <18 years or legal incapacity.

研究组 & 干预措施

Dual-Shock 400J

Experimental

ECV with dual shock technique. Double pad configuration with electrodes both in antero-lateral and antero-posterior location. Total energy deliver: 400J.

干预措施: Dual-shock Electrical Cardioversion (Procedure)

Conventional Electrical Cardioversion

Active Comparator

Conventional ECV with single pad configurataion in antero-lateral or antero-posterior location. Energy deliver: 200J

干预措施: Conventional Electrical Cardioversion (Procedure)

Dual-Shock 200J

Experimental

ECV with dual shock technique. Double pad configuration with electrodes both in antero-lateral and antero-posterior location. Total energy deliver: 200J.

干预措施: Dual-shock Electrical Cardioversion (Procedure)

结局指标

主要结局

Primary Efficacy Outcome - Patients achieving sinus rhythm with the first shock

时间窗: First minute after first shock delivery

Percentage of patients achieving sinus rhythm with the first shock deliver. Three consecutive beats in sinus rhythm are neccesary to consider sinus rhythm achieved.

Primary Safety Outcome - Adverse events during the procedure

时间窗: Before patient are discharged

Ocurrence of any complication during the ECV. Arrhythmic recurrences of atrial fibrillation will not be considered as complications.

次要结局

  • Overall Procedural Sucess(The end of the procedure)
  • Overall Intervention-Specific Success(First minute after shock delivery)
  • Total Energy Delivered(End of the procedure)
  • Sub-acute procedural success(At 30 (25-35) days after the procedure)

研究者

发起方
Martín Negreira Caamaño, MD, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Martín Negreira Caamaño, MD, PhD

Principal Investigator and Sponsor.

Hospital Universitario Getafe

相似试验